Episomal Vectors for Stable Production of Recombinant Proteins and Engineered Antibodies
Antibodies · 11.03.2024 · 13 (1) · 18
DOI: 10.3390/antib13010018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibodies, online erschienen am 11.03.2024. Verfasst von Ian Fallahee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the National Multiple Sclerosis Society.
Abstract (Originalsprache)
There is tremendous interest in the production of recombinant proteins, particularly bispecific antibodies and antibody–drug conjugates for research and therapeutic use. Here, we demonstrate a highly versatile plasmid system that allows the rapid generation of stable Expi293 cell pools by episomal retention of transfected DNA. By linking protein expression to puromycin resistance through an attenuated internal ribosome entry site, we achieve stable cell pools producing proteins of interest. In addition, split intein–split puromycin-mediated selection of two separate protein expression cassettes allows the stable production of bispecific antibody-like molecules or antibodies with distinct C-terminal heavy chain modifications, such as an antigen on one chain and a sortase tag on the other chain. We also use this novel expression system to generate stable Expi293 cell pools that secrete sortase A Δ59 variant Srt4M. Using these reagents, we prepared a site-specific drug-to-antibody ratio of 1 antibody–siRNA conjugate. We anticipate the simple, robust, and rapid stable protein expression systems described here being useful for a wide variety of applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.
ORCID-Profile: Daniel Hawiger
Förderung
- NIAID NIH HHS
- the National Institute of Allergy and Infectious Diseases of the National Institutes of Health
- the National Multiple Sclerosis Society
Zitieren
APA
Fallahee, I., & Hawiger, D. (2024). Episomal Vectors for Stable Production of Recombinant Proteins and Engineered Antibodies. Antibodies, 13(1), 18. https://doi.org/10.3390/antib13010018
Vancouver
Fallahee I, Hawiger D. Episomal Vectors for Stable Production of Recombinant Proteins and Engineered Antibodies. Antibodies. 2024;13(1):18. doi:10.3390/antib13010018
BibTeX
@article{Fallahee2024,
author = {Fallahee, Ian and Hawiger, Daniel},
title = {Episomal Vectors for Stable Production of Recombinant Proteins and Engineered Antibodies},
journal = {Antibodies},
year = {2024},
volume = {13},
number = {1},
pages = {18},
doi = {10.3390/antib13010018}
}
EUVIMED